Menu
  • CAPRISA participates at the DST-NRF CoE Directors' Forum

    A National Institutes of Health U01 grant was recently awarded to CAPRISA Research Associate Professor Lynn Morris as part of the H3Africa initiative. This grant aims to examine antibody gene diversity and its impact on neutralizing and non-neutralizing functions. It builds on previous studies by Catherine Scheepers showing a high frequency of novel alleles in the CAPRISA cohort as well as work by Bronwen Lambson and Simone Richardson, at the Nation-al Institutes of Communicable Dis-eases (NICD), on how changes in the Fc region impact effector functions.  It is hoped, “that this work will help to better understand the human antibody response to HIV infection and ultimately inform vaccine development,” explained Morris, who is a Research Professor in the Faculty of Health Sciences at the University of Witwatersrand and is the Head of the HIV Virology Laboratory in the Centre for HIV & STIs at the NICD.

    Share this article

    Back

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.